文献速递耳科与耳神经鼻科

度普利尤单抗使重症嗜酸性中耳炎完全缓解:病例报告

Complete Remission of Severe Eosinophilic Otitis Media With Dupilumab: A Case Report.
PubMed 文献 · Laryngoscope · 2021-07-03

本病例报告描述一名重症嗜酸性中耳炎伴严重混合性听力损失、接近功能性耳聋的患者,接受度普利尤单抗治疗后嗜酸性中耳炎获得完全且持久缓解,听力康复得以实施,同时合并的哮喘和慢性鼻窦炎伴鼻息肉也得到控制。

要点

  • 嗜酸性中耳炎与2型炎症相关,常合并哮喘和慢性鼻窦炎伴鼻息肉。
  • 度普利尤单抗可使重症嗜酸性中耳炎完全且持久缓解。
  • 生物治疗缓解耳部病变同时有助于听力康复和共病控制。

核心结论

  • 度普利尤单抗治疗使重症嗜酸性中耳炎获得完全且持久的缓解,并实现听力康复。

研究设计与样本

  • 病例报告,描述一名重症嗜酸性中耳炎伴严重混合性听力损失、接近功能性耳聋的患者。

主要发现

  • 度普利尤单抗治疗后嗜酸性中耳炎完全且持久缓解,听力康复得以实施。
  • 合并的哮喘和慢性鼻窦炎伴鼻息肉同时获得控制。

临床怎么用

  • 对重症嗜酸性中耳炎合并2型炎症呼吸疾病患者,可考虑度普利尤单抗治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Eosinophilic otitis media (EOM) is a difficult-to-treat otitis media (OM) characterized by eosinophilic accumulation in the middle ear mucosa and secretion. Associated sensorineural hearing loss can eventually lead to (functional) deafness. EOM is strongly associated with type 2 inflammation driven respiratory disease, i.e. asthma and chronic rhinosinusitis with nasal polyps (CRSwNP), for which biological treatment is available. This case report discusses a patient suffering from EOM with severe mixed hearing loss, nearing functional deafness. Dupilumab treatment resulted in complete and enduring remission of the EOM, enabling adequate hearing rehabilitation. Concurrent control of the comorbid asthma and CRSwNP was obtained. Laryngoscope, 131:2649-2651, 2021.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. van der Lans RJL, van Spronsen E, Fokkens WJ, et al. Complete Remission of Severe Eosinophilic Otitis Media With Dupilumab: A Case Report. Laryngoscope. 2021. PMID: 34216146. doi:10.1002/lary.29730

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。